TEMECULA, Calif., Oct. 13, 2014 (GLOBE NEWSWIRE) -- Unexpected delays from multiple manufacturers are causing postponements of flu shipments to some healthcare providers who are just beginning their fall vaccination campaigns.
FFF Enterprises has a large supply of flu vaccines that are ready to be shipped from their two state-of-the-art distribution facilities, located in Temecula, CA and Kernersville, NC, to hospitals, physician offices, retail outlets, clinics, worksites and senior centers nationwide.
"The flu impacts hundreds of thousands of people in the U.S. every year, and each year FFF strives to ensure that patients will receive their flu vaccinations, from their healthcare provider of choice, in time for protection each season," says Patrick M. Schmidt, FFF's chief executive officer. "Public health preparedness is essential to the well-being of our communities, and ensuring flu vaccines are available and distributed in a timely manner is critical in the overall public health landscape."
FFF is an authorized distributor of all U.S. licensed manufacturers and brands. FFF carries bioCSL, GlaxoSmithKline, MedImmune, Novartis and Sanofi Pasteur. And their respective brands, Afluria, FluLaval, Fluarix, FluMist, Fluvirin and Fluzone.
Also available are cell-based Flucelvax by Novartis and recombinant cell-cultured Flublok by Protein Sciences.
"And FFF never raises its prices during flu vaccine delays. The prices we offer today are the same we offered when the ordering season kicked off in January," says Schmidt.
FFF is an industry leader in the pharmaceutical supply chain. The company has developed advanced technologies that set it apart from its competitors. FFF's Guaranteed Channel Integrity™ has resulted in 26 years of counterfeit-free product distribution. In addition, its Verified Electronic Pedigree™ (VEP) system electronically displays the chain of custody for every product that moves through its safe channel, its LotTrack™ service tracks products by lot number and provides recall notification to those affected, and the MyFluVaccine™ program has revolutionized the flu vaccine marketplace by making it easier to order multiple products and choose convenient delivery date(s).
For media inquiries, call 800.843.7477.
CONTACT: Scott Southward Public Relations and Communications Manager Office: 951-296-2500, ext. 1212 Cell: 951-297-8998 Fax: 951-699-9655